NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
»18/05/2010 [Industry news]
OriGene Technologies, Inc. To Build The World Largest TrueMAB Monoclonal Antibody Facility In Wuxi, China

 
OriGene Technologies, Inc. To Build The World\'s Largest TrueMAB? Monoclonal Antibody Facility In Wuxi, China , May 18 OriGene Technologies, Inc. with the support of Wuxi Biopharmaceutical R&D Outsourcing Services Park (China), will build one of the largest and most sophisticated monoclonal antibody production centers in the world in Wuxi, China. The new, high-throughput production facility is expected to have over one thousand employees with the capacity to produce over 20,000 TrueMAB? antibodies per year. Monoclonal antibodies have become an invaluable tool for researchers to develop diagnostic and therapeutic applications. TrueMAB? antibodies from OriGene are generated using OriGene\'s large collection of full-length human proteins as primary antigens that have been affinity purified under native conditions to preserve natural protein conformations. As a result, TrueMAB? antibodies provide higher sensitivity and specificity for the recognition of native epitopes on the protein\'s natural conformational structures. With the introduction of OriGene\'s TrueMAB? antibodies, OriGene now provides higher quality and greater numbers of monoclonal antibodies to the global research market place to address complex applications such as flow cytometry, ELISA, IHC, antibody arrays, Luminex assays and more.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.